Raymond James Financial
YARW

Raymond James Financial’s Yarrow Bioscience YARW Stock Holding History

Raymond James Financial’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-443
Closed -$36.6K – 6766
2025
Q2 		$36.6K Buy
+443
New +$28.8K ﹤0.01% 5308

Other funds holding YARW

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Raymond James Financial's YARW Position: Q3 2025 in Review

Raymond James Financial sold out of Yarrow Bioscience (YARW) in Q3 2025, closing a stake of 443 shares — an estimated $36.6K sold.

Raymond James Financial first reported a position in YARW in Q2 2025 and held it in 1 quarter. The position peaked at $36.6K in Q2 2025. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

  • Raymond James Financial reported no remaining Yarrow Bioscience position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 443 Yarrow Bioscience shares in Q3 2025, an estimated $36.6K.
  • Raymond James Financial first reported a position in Yarrow Bioscience in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Yarrow Bioscience position peaked at $36.6K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.